期刊文献+

胰岛素泵对2型糖尿病慢性肾脏疾病患者不同时期体内氧化应激水平影响的观察 被引量:7

Effect of insulin pump on oxidative stress in T2DM patients with CKD in different courses
原文传递
导出
摘要 目的探讨短期胰岛素泵强化治疗对糖尿病慢性肾脏疾病(CKD)患者不同时期体内氧化应激水平的影响。方法选取T2DM患者80例为T2DM组,再根据白蛋白尿/肌酐比值(UACR)分为正常白蛋白尿(NA)亚组,微量白蛋白尿(MA)亚组,临床肾病(CA)亚组。另选同期健康体检者30名为正常对照(NC)组,应用胰岛素泵对T2DM组强化治疗2周,比较治疗前后氧化应激指标8-羟基脱氧鸟苷(8-OHdG)、3-硝基酪氨酸(3-NT)、谷胱甘肽(GSH)及超氧化物歧化酶(SOD)的变化情况。结果 (1)治疗前T2DM组8-OHdG、3-NT、HbA1c、BUN、Cr水平及胰岛素抵抗指数(HOMA-IR)高于NC组,且随着UACR增加而增加,组间差异有统计学意义(P<0.05);T2DM组GSH、SOD水平低于NC组(P<0.05),且随着UACR增加而降低,但NA、MA、CA组间GSH、SOD比较差异无统计学意义(P>0.05)。(2)治疗后T2DM组血压、血糖、TG、TC、LDL-C、HOMA-IR较治疗前均下降;HDL-C升高,差异有统计学意义(P<0.05);但HbA1c治疗前后差异无统计学意义(P>0.05)。(3)治疗后NA、MA、CA组8-OHdG、3-NT水平降低;GSH、SOD水平升高。但NA、MA组变化较CA组显著,差异有统计学意义(P<0.05)。(4)相关分析显示,8-OHdG、3-NT和HbA1c、病程、HOMA-IR及FPG呈正相关,GSH、SOD和HbA1c、病程、HOMA-IR及FPG呈负相关。结论 CKD早期使用胰岛素泵强化治疗可改善患者体内氧化应激水平,延缓或阻止向临床肾病期和终末期肾病进展。 Objective To explore the effect of short-term insulin pump intensive therapy on oxidative stress (OS) in T2DM nephropathy patients in different courses. Methods Eighty T2DM patients were divided, according to urine albumin /creatinine ratio (UACR), into three groups: normal albuminuria (NA), micro albuminuria (MA), clinical albuminuria (CA), and thirty healthy persons were randomly chosen as normal control (NC) group. After two weeks insulin pump intensive therapy, the levels of oxidative stress indexes 8-hydroxy deoxyguanosine (8-OhdG), 3-nitrotyrosine (3-NT), glutathione (GSH), and superoxide dismutase (SOD) of the T2DM group were detected and compared. Results (1). Before the insulin pump intensive therapy, in the T2DM group the levels of 8-OhdG, 3- NT, HbA1c, BUN, Cr level, and IR index (HOME-IR) were higher than those in the NC group, and they were increasing with the UACR increasing, and there was significant difference shown among all the groups (P〈0.05); the levels of GSH and SOD in the T2DM group were lower than those in the NC group (P〈0.05),and they were decreasing with the UACR increasing, and there was no significant difference shown among the NA, MA, and CA groups (P〉0.05). (2). After the insulin pump intensive therapy, the blood pressure, blood glucose, TG, TC, LDL-C, and HOME-IR were significantly lowered than before treatment, and HDL-C increased (P〈0.05), however, the level of HbA1c was not statistically different in the T2DM group (P〉0.05). (3). After the insulin pump intensive therapy, the 8-OhdG and 3-NT levels reduced, GSH and SOD levels raised in the NA, MA, and CA groups, whilst the changes in the NA and MA groups were more significant than in the CA group (P〈0.05). (4). Correlation analysis showed that: the 8-OhdG and 3-NT levels were correlated positively with HbA1c, course of disease, HOME-IR, and FPG, but the GSH and SOD levels were negatively correlated with HbA1c, course of disease, HOME-IR, and FPG. Conclusion In the early stage of DN, using insulin pump intensive therapy can markedly improve the oxidative stress level inside the patients, and can slow down or stop the progress to the clinical albuminuria period and end-stage of renal disease.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第5期429-432,共4页 Chinese Journal of Diabetes
关键词 糖尿病肾病 氧化应激 胰岛素泵强化治疗 Diabetic nephropathy Oxidative stress Insulin pump intensive therapy
  • 相关文献

参考文献5

  • 1Deunis MS, Zhang M, Meng YG, et al. Albumin binding as a general strategy forimproving the pharmaeokineties of pro- teins. J Biol Chem, 2002, 277 :35035-35043.
  • 2Kitada M, Kume S, Imaizumi N, et al. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/ SIRTl-independent pathway. Diabetes, 2011, 60.. 634-643.
  • 3Pan HZ, Zhang L, Guo MY, et al. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol, 2010, 47(Suppl 1) :71-76.
  • 4The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the develop- ment and progression of long-term complications in insulin-de- pendent diabetes mellitus. N EnglJ Med, 1993, 329:997-986.
  • 5UKProspective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in pa- tients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352: 837-853.

同被引文献56

  • 1安娜,刘惠兰,王英.2型糖尿病肾病大鼠肾小管间质病变及TGF-β1、HGF和CTGF表达的变化及意义[J].首都医科大学学报,2008,29(3):315-320. 被引量:12
  • 2杨莹,吴于滨,宋滇平.氧化应激与糖尿病肾病的分子机制[J].昆明医学院学报,2007,28(02B):100-103. 被引量:1
  • 3中华医学会糖尿病分会.中国2型糖尿病防治指南[M].北京:北京医科大学出版社,2007:33.
  • 4Delgado M A, Zamorano J L. Atorvastatin calcium plus amlodipine for the treatment of hypertension [ J ]. Expert Opin Pharmacother, 2012,13 ( 18 ) :2673-2685.
  • 5Kotlega D, Ciecwiez S, Turowska K J, et al. Pathogenet- ic justification of statin use in isehaemie stroke prevention according to inflammatory theory in development of ather- oselerosis[ J]. Neurol Neurochir Pol, 2012,46 (2) : 176- 183.
  • 6Padhy B M, Yadav R, Gupta Y K. Hypolipidaemic and anti-inflammatory effects of fixed dose combination of atorvastatin plus ezetimibe in Indian patients with dyslipi- daemia[ J]. Singapore Med J, 2013,54 (2) :90-95.
  • 7Yamagishi S, Fukami K, Ueda S, et al. Molecular mech-anism of diabetic nephropathy and its therapeutic inter- vention [ J ]. Curr Drug Targets, 2007,8 ( 8 ) : 952-959.
  • 8Goh S Y, Cooper M E. Clinical review: The role of ad- vanced glyeation end products in progression and compli- cations of diabetes[ J ]. J Clin Endocrinol Metab, 2008, 93(4) :1143-1152.
  • 9Chen S, Ziyadeh F N. Vascular endothelial growth factor and diabetic nephropathy [ J ]. Curr Diab Rep, 2008,8 (6) :470-476.
  • 10Navarro J F, Mora C, Muros M, et al. The role of in- flammatory cytokines in diabetic nephropathy [ J ]. J Am Soc Nephrol, 2008,19 (3) :433-442.

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部